Rxo (RXO) Total Debt (2022 - 2026)

Rxo (RXO) has reported Total Debt for 5 consecutive years, with $447.0 million the latest figure, recorded in Q1 2026.

• Total Debt for Q1 2026 came in at $447.0 million, up 10.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $447.0 million (up 10.64% YoY), and the FY2025 annual result was $404.0 million, up 9.78% from the prior year.
• Total Debt was $447.0 million for Q1 2026 at Rxo, up from $404.0 million in the prior quarter.
• Over five years, Total Debt peaked at $455.0 million in Q4 2022 and troughed at $11.0 million in Q3 2022.
• Average Total Debt over 5 years is $382.5 million, with a median of $403.0 million recorded in 2025.
• The widest YoY moves for Total Debt: up 4027.27% in 2023, down 21.1% in 2023.
• Over 5 years, Total Debt stood at $455.0 million in 2022, then retreated by 21.1% to $359.0 million in 2023, then gained by 2.51% to $368.0 million in 2024, then gained by 9.78% to $404.0 million in 2025, then advanced by 10.64% to $447.0 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $447.0 million in Q1 2026, $404.0 million in Q4 2025, and $403.0 million in Q3 2025.